CM Life Sciences Inc.

NASDAQ: CMLF · Real-Time Price · USD
11.60
-0.88 (-7.05%)
At close: Jul 23, 2021, 6:00 AM

CM Life Sciences Revenue Breakdown

Period Ending Dec 31, 2024
Diagnostic Test Revenue 302.16M
Diagnostic Test Revenue Growth n/a
Diagnostic Test, Institutional Customers Revenue 65.11M
Diagnostic Test, Institutional Customers Revenue Growth n/a
Diagnostic Test, Self Pay Revenue 2.34M
Diagnostic Test, Self Pay Revenue Growth n/a
Diagnostic Test, Third Party Insurance Revenue 234.7M
Diagnostic Test, Third Party Insurance Revenue Growth n/a
Product and Service, Other Revenue 3.29M
Product and Service, Other Revenue Growth n/a

Revenue by Geography

Period Ending Dec 31, 2024
Other Revenue 3.16M
Other Revenue Growth n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Jun 30, 2023 Jun 30, 2021 Dec 31, 2020
Selling, General, and Administrative Revenue 46.86M 50.45M 45.03M 43.17M 41.76M 52.52M 1.28M 206.19K
Selling, General, and Administrative Revenue Growth -7.11% +12.05% +4.30% +3.39% -20.50% +4009.78% +519.80% n/a
Research and Development Revenue 15.08M 12.58M 11.59M 11.66M 10.9M 17.14M n/a n/a
Research and Development Revenue Growth +19.89% +8.53% -0.66% +7.00% -36.39% n/a n/a n/a
Sales and Marketing Revenue 19.45M 18.32M 17.68M 17.02M 16.59M 15.18M n/a n/a
Sales and Marketing Revenue Growth +6.18% +3.62% +3.82% +2.65% +9.24% n/a n/a n/a